Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_provenance.
- NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_assertion description "[The TOV-21G, TOV-81D, OV-90, and TOV-112D cell lines were derived from ovarian tumors (TOV) or ascites (OV) from chemotherapy- and radiotherapy-naive patients and were characterized by their mutation spectrum of BRCA2, TGFbeta-RII, KRAS2, TP53, and CDKN2A.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_provenance.
- NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_assertion evidence source_evidence_literature NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_provenance.
- NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_assertion SIO_000772 15258697 NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_provenance.
- NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_assertion wasDerivedFrom befree-2016 NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_provenance.
- NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_assertion wasGeneratedBy ECO_0000203 NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_provenance.
- befree-2016 importedOn "2016-02-19" NP452432.RAtPrRe9bPoO6eLlVT-cC4gRzytFgxPww6zjbmesirgFE130_provenance.